Tag: PTIE

Finance

Today’s Hot List : Baidu (NASDAQ:BIDU), BlackBerry Ltd (NASDAQ:BBRY), Pain Therapeutics (NASDAQ:PTIE), Inland Real Estate Corp. (NYSE:IRC), City Holding Co. (NASDAQ:CHCO)

Baidu Inc (ADR) (NASDAQ:BIDU), Chinese web services company, has launched a new service that will help retailers to advertise on mobile devices for all the users of Baidu search engine, Reuters reported. This new feature will increase Baidu Inc (ADR) (NASDAQ:BIDU)’s revenues and will give it a huge boost in the market, as according to the statistics issued by the Chinese government, the majority of users in China access internet from their smartphones … Continue reading Today’s Hot List : Baidu (NASDAQ:BIDU), BlackBerry Ltd (NASDAQ:BBRY), Pain Therapeutics (NASDAQ:PTIE), Inland Real Estate Corp. (NYSE:IRC), City Holding Co. (NASDAQ:CHCO)

Mark Doerr
Finance

Best Stocks : Pain Therapeutics (NASDAQ:PTIE), Symantec (NASDAQ:SYMC), Hormel Foods (NYSE:HRL), Overstock.com Inc. (NASDAQ:OSTK), The Travelers. (NYSE:TRV)

Pain Therapeutics Inc. (NASDAQ:PTIE), announced recently that they expect to start a Phase 1 clinical trial with ORADUR®-Hydromorphone shortly with an expectation of starting a Phase 3 trial for this product candidate in 2015.  Other programs, some of which are partnered and some of which are currently unpartnered, are progressing as well.” Pain Therapeutics Inc. (NASDAQ:PTIE) belongs to Healthcare sector. Its net profit margin is … Continue reading Best Stocks : Pain Therapeutics (NASDAQ:PTIE), Symantec (NASDAQ:SYMC), Hormel Foods (NYSE:HRL), Overstock.com Inc. (NASDAQ:OSTK), The Travelers. (NYSE:TRV)

Jayne Crisman
Finance

Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Celgene Corporation (NASDAQ:CELG)’s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Thursday. They currently have a $225.00 price target on the stock, up from their previous price target of $210.00. Credit Suisse’s target price would suggest a potential upside of 31.23% from the company’s current price. Celgene Corporation (NASDAQ:CELG) stock performance was 0.88% in last session and finished … Continue reading Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Richard Atkins
Finance

Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of results from a multiple-dose study, conducted by Kyowa Hakko Kirin Pharma, Inc. (KKP), of the investigational anti-FGF23 monoclonal antibody KRN23 (UX023) in adult patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, … Continue reading Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Jayne Crisman